IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040.
By K. Ogurtsova, J. Fernandes, Yadi Huang, U. Linnenkamp, L. Guariguata, Nam H. Cho, David A. Cavan, J. Shaw, Lydia Makaroff. Diabetes Research and Clinical Practice, 2011
5,092 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Organizational Behavior and Human Resource Management
View Paper: https://www.semanticscholar.org/paper/5b9415e48252adc2aa3b63f449a29b28ba89aeb6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Endocrinology, Diabetes and Metabolism
Citations in the corpus
- Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms (2017, background): “It is predicted that the number of cases of T2D will rise from 415 million to 642 million by 2040.(1) Hypertension is even more common, rising in prevalence in the same countries, with a recent worldwide estimate of 1.”
- Data-Driven Blood Glucose Pattern Classification and Anomalies Detection: Machine-Learning Applications in Type 1 Diabetes (2019, background): “The total number of deaths attributed to diabetes is estimated to be 5 million in people with diabetes aged between 20 and 79 years [1].”
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes (2019, positive): “The prevalence is increasing, and it is expected that more than 640 million adults will have diabetes by 2040.(1) Patients with diabetes are at high risk for adverse outcomes from atherosclerotic cardiovascular disease,(2,3) heart failure,(4) and renal disease.”
- Insulin resistance: Review of the underlying molecular mechanisms (2018, background): “The prevalence of diabetes mellitus (DM) is rapidly increasing worldwide, due largely to considerable changes in modern human lifestyle (Ogurtsova et al., 2017).”